To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed TScan Therapeutics raises $100m for IPO
TScan Therapeutics, a biopharmaceutical company, has raised about $100 million for its IPO after pricing its over 6.6 million shares at $15 per share.
